![Michelle Greenman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Greenman
General Counsel bei
FATE THERAPEUTICS, INC.
Profil
Ms. Michelle Greenman is a Vice President-Regulatory Affairs at Fate Therapeutics, Inc. Ms. Greenman was previously employed as a Vice President-Global Regulatory Affairs by Kezar Life Sciences, Inc. She received her undergraduate degree from Gustavus Adolphus College and a doctorate degree from Northwestern Health Sciences University.
Aktive Positionen von Michelle Greenman
| Unternehmen | Position | Beginn |
|---|---|---|
| FATE THERAPEUTICS, INC. | General Counsel | 01.01.2026 |
Ehemalige bekannte Positionen von Michelle Greenman
| Unternehmen | Position | Ende |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | General Counsel | 01.11.2025 |
Ausbildung von Michelle Greenman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Gustavus Adolphus College
 Gustavus Adolphus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Northwestern Health Sciences University
 Northwestern Health Sciences University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
